$WVE
Wave Life Sciences Ltd.

2016 Q4 Form 10-Q Financial Statement

#000156459016028710 Filed on November 09, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q3
Revenue $676.0K $392.0K $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.190M $3.940M $2.860M
YoY Change 38.4% 37.76% 271.43%
% of Gross Profit
Research & Development $14.00M $13.69M $2.132M
YoY Change 303.46% 541.93% 264.44%
% of Gross Profit
Depreciation & Amortization $250.0K $190.0K $280.0K
YoY Change 92.31% -32.14% 180.0%
% of Gross Profit
Operating Expenses $19.18M $17.63M $4.990M
YoY Change 165.87% 253.21% 268.54%
Operating Profit -$18.50M -$17.23M -$4.990M
YoY Change 156.5% 245.35% 268.54%
Interest Expense $260.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$20.00K $80.00K $137.0K
YoY Change 0.0% -41.61% 448.0%
Pretax Income -$18.27M -$17.15M -$4.853M
YoY Change 152.35% 253.41% 265.16%
Income Tax $190.0K $384.0K $83.00K
% Of Pretax Income
Net Earnings -$18.45M -$17.54M -$4.936M
YoY Change 159.95% 255.25% 262.14%
Net Earnings / Revenue -2729.88% -4473.21%
Basic Earnings Per Share
Diluted Earnings Per Share -$785.4K -$748.0K -$535.8K
COMMON SHARES
Basic Shares Outstanding 23.48M 23.44M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $150.3M $169.0M $66.00M
YoY Change -6.76% 156.06%
Cash & Equivalents $150.3M $169.0M $66.04M
Short-Term Investments
Other Short-Term Assets $1.700M $600.0K $1.900M
YoY Change 1600.0% -68.42%
Inventory
Prepaid Expenses
Receivables $2.500M $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $152.0M $172.1M $67.99M
YoY Change -5.82% 153.2%
LONG-TERM ASSETS
Property, Plant & Equipment $8.607M $6.693M $1.954M
YoY Change 208.61% 242.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.200M $1.100M $1.100M
YoY Change 223.08% 0.0%
Total Long-Term Assets $12.82M $7.833M $3.009M
YoY Change 217.35% 160.32%
TOTAL ASSETS
Total Short-Term Assets $152.0M $172.1M $67.99M
Total Long-Term Assets $12.82M $7.833M $3.009M
Total Assets $164.8M $180.0M $71.00M
YoY Change -0.37% 153.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.943M $3.825M $2.875M
YoY Change 75.84% 33.04%
Accrued Expenses $4.400M $4.800M $100.0K
YoY Change 633.33% 4700.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $100.0K $100.0K
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $12.16M $11.43M $3.474M
YoY Change 218.36% 228.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $100.0K
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $796.0K $522.0K $31.00K
YoY Change 388.34% 1583.87%
Total Long-Term Liabilities $9.919M $9.540M $125.0K
YoY Change 4015.77% 7532.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.16M $11.43M $3.474M
Total Long-Term Liabilities $9.919M $9.540M $125.0K
Total Liabilities $22.07M $20.97M $3.599M
YoY Change 443.83% 482.52%
SHAREHOLDERS EQUITY
Retained Earnings -$90.48M -$72.02M -$27.98M
YoY Change 157.95% 157.44%
Common Stock $215.6M $215.5M $22.45M
YoY Change 16.33% 860.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $134.6M $151.1M -$3.120M
YoY Change
Total Liabilities & Shareholders Equity $164.8M $180.0M $71.00M
YoY Change -0.37% 153.5%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income -$18.45M -$17.54M -$4.936M
YoY Change 159.95% 255.25% 262.14%
Depreciation, Depletion And Amortization $250.0K $190.0K $280.0K
YoY Change 92.31% -32.14% 180.0%
Cash From Operating Activities -$13.35M -$11.83M -$2.850M
YoY Change 100.15% 315.09% 139.5%
INVESTING ACTIVITIES
Capital Expenditures -$2.730M -$1.280M -$510.0K
YoY Change 181.44% 150.98% 1175.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities -$2.730M -$1.270M -$510.0K
YoY Change 181.44% 149.02% 1175.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.00K 190.0K 61.21M
YoY Change -99.99% -99.69%
NET CHANGE
Cash From Operating Activities -13.35M -11.83M -2.850M
Cash From Investing Activities -2.730M -1.270M -510.0K
Cash From Financing Activities 10.00K 190.0K 61.21M
Net Change In Cash -16.07M -12.91M 57.85M
YoY Change -116.9% -122.32% -4803.25%
FREE CASH FLOW
Cash From Operating Activities -$13.35M -$11.83M -$2.850M
Capital Expenditures -$2.730M -$1.280M -$510.0K
Free Cash Flow -$10.62M -$10.55M -$2.340M
YoY Change 86.32% 350.85% 103.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Income Loss
NetIncomeLoss
-12101000
us-gaap Net Income Loss
NetIncomeLoss
-36947000
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.75
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9223405
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3818000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161220000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
161384000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
169015000
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23475469
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2858000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
17625000
CY2015Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
78000
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2500000
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
625000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
146000
CY2016Q3 us-gaap Assets Current
AssetsCurrent
172140000
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6693000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2789000
CY2016Q3 us-gaap Assets
Assets
179973000
CY2015Q4 us-gaap Assets
Assets
165424000
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3825000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2811000
CY2016Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4833000
CY2015Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
945000
CY2016Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
62000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
18000
CY2016Q3 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
32000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
192000
CY2016Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1055000
CY2016Q3 us-gaap Other Assets
OtherAssets
53000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
72857000
us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
-67000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66040000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1595000
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21551423
CY2016Q3 us-gaap Revenues
Revenues
392000
us-gaap Revenues
Revenues
809000
us-gaap Revenues
Revenues
152000
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13686000
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2132000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26823000
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3939000
us-gaap Operating Income Loss
OperatingIncomeLoss
-12084000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
10000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-25000
CY2015Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
62000
CY2016Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2705000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
155000
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
137000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
303000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
165000
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17151000
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2181000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4853000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36520000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11919000
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
384000
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11425000
CY2016Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
31000
CY2016Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
8987000
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
522000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
163000
CY2016Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
9540000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
83000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
427000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
182000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-17535000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-4936000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.64
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23445673
CY2015Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
241000
CY2016Q3 us-gaap Liabilities
Liabilities
20965000
CY2015Q4 us-gaap Liabilities
Liabilities
4059000
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
215505000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
185344000
CY2016Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7568000
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3182000
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
84000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
41000
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72023000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35076000
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
151134000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
153491000
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
179973000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
165424000
CY2016Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2015Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23474369
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21551423
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23474369
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12114000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
525000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
462000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4319000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3210000
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
371000
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-4000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
178000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
182000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
67000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2500000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-193000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
466000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
40000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
53000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1899000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2464000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2484000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-73000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
11692000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-152000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-13000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-18578000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5859000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
1055000
wve Proceeds From Government Grant Reimbursements For Property And Equipment
ProceedsFromGovernmentGrantReimbursementsForPropertyAndEquipment
3000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2838000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
887000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2834000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1939000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30000000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11631000
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
62643000
wve Proceeds From Government Grant
ProceedsFromGovernmentGrant
112000
us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
1075000
us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
1417000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
47000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
112000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
161000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
67000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
29106000
us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
101000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7795000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
64992000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1048000
wve Reclassifications From Permanent Equity To Temporary Equity
ReclassificationsFromPermanentEquityToTemporaryEquity
7874000
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
268000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
319000
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
718000

Files In Submission

Name View Source Status
0001564590-16-028710-index-headers.html Edgar Link pending
0001564590-16-028710-index.html Edgar Link pending
0001564590-16-028710.txt Edgar Link pending
0001564590-16-028710-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wve-10q_20160930.htm Edgar Link pending
wve-20160930.xml Edgar Link completed
wve-20160930.xsd Edgar Link pending
wve-20160930_cal.xml Edgar Link unprocessable
wve-20160930_def.xml Edgar Link unprocessable
wve-20160930_lab.xml Edgar Link unprocessable
wve-20160930_pre.xml Edgar Link unprocessable
wve-ex101_177.htm Edgar Link pending
wve-ex102_178.htm Edgar Link pending
wve-ex103_179.htm Edgar Link pending
wve-ex104_180.htm Edgar Link pending
wve-ex105_181.htm Edgar Link pending
wve-ex311_9.htm Edgar Link pending
wve-ex312_8.htm Edgar Link pending
wve-ex321_7.htm Edgar Link pending
wve-ex322_6.htm Edgar Link pending